CN Stock MarketDetailed Quotes

001367 Zhejiang Haisen Pharmaceutical

Watchlist
  • 28.34
  • -1.29-4.35%
Market Closed Nov 15 15:00 CST
2.91BMarket Cap24.31P/E (TTM)

Zhejiang Haisen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
-10.44%283.17M
-8.50%193.37M
14.87%106.95M
8.69%422.78M
316.17M
13.27%211.34M
Operating revenue
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
-10.44%283.17M
-8.50%193.37M
14.87%106.95M
8.69%422.78M
--316.17M
13.27%211.34M
Other operating revenue
----
-53.80%432.99K
----
-28.82%1.17M
----
-20.47%937.11K
----
-25.17%1.64M
----
--1.18M
Total operating cost
9.41%220.99M
3.15%145.3M
-0.08%77.41M
-8.61%277.74M
-10.13%201.98M
-4.76%140.86M
20.27%77.46M
7.25%303.91M
224.76M
7.43%147.9M
Operating cost
10.57%187.65M
5.40%124.36M
4.66%70.51M
-11.57%234.18M
-14.85%169.7M
-10.18%117.99M
20.57%67.37M
13.42%264.82M
--199.29M
15.92%131.36M
Operating tax surcharges
16.24%3.35M
7.46%2.25M
17.00%892.61K
95.38%4.16M
32.34%2.88M
121.45%2.1M
68.15%762.88K
-31.83%2.13M
--2.18M
-34.12%946.82K
Operating expense
8.26%8.67M
14.19%6M
-10.76%1.71M
4.22%10.46M
4.69%8M
1.61%5.26M
3.04%1.92M
5.22%10.04M
--7.65M
17.02%5.18M
Administration expense
-9.05%18.2M
-13.62%11.98M
5.29%5.07M
14.53%26.03M
18.35%20.01M
20.67%13.87M
-2.82%4.82M
-5.93%22.73M
--16.91M
7.14%11.49M
Financial expense
-33.27%-14.69M
-76.41%-10.88M
-1,133.71%-5.06M
-37.70%-15.94M
-4.70%-11.03M
10.19%-6.17M
57.24%-410.42K
-1,283.18%-11.58M
---10.53M
-1,080.33%-6.87M
-Interest expense (Financial expense)
986.72%279.12K
467.99%184.52K
467.99%92.26K
-49.99%33.96K
-50.28%25.68K
-8.26%32.49K
-33.95%16.24K
-32.93%67.9K
--51.66K
-31.96%35.41K
-Interest Income (Financial expense)
-32.28%-13.28M
-68.25%-9.17M
-213.59%-4.12M
-330.91%-15.3M
-348.33%-10.04M
-303.92%-5.45M
-126.59%-1.31M
-131.28%-3.55M
---2.24M
-206.09%-1.35M
Research and development
43.61%17.83M
48.10%11.59M
42.58%4.28M
19.50%18.84M
33.87%12.42M
34.89%7.82M
35.60%3M
30.65%15.77M
--9.28M
-17.96%5.8M
Credit Impairment Loss
50,837.53%799.76K
151.35%425.21K
90.25%-54.86K
44.38%-427.52K
99.89%-1.58K
68.17%-828.11K
---562.68K
-764.87%-768.63K
---1.46M
-220.08%-2.6M
Asset Impairment Loss
-21.81%-592.85K
-32.50%-545.51K
---306.99K
-107.81%-2.44M
41.90%-486.71K
55.68%-411.69K
----
37.26%-1.17M
---837.64K
-20.73%-928.84K
Other net revenue
19.76%2.58M
309.42%2.03M
240.24%706.85K
-18.50%2.26M
53.63%2.15M
170.32%496.32K
-256.74%-504.04K
-14.71%2.77M
1.4M
-166.10%-705.82K
Fair value change income
----
----
----
----
----
----
----
-200.00%-740.3K
---740.3K
---3.38M
Invest income
--174.27K
----
----
110.30%319.69K
----
----
----
-536.86%-3.11M
---3.11M
-98.02%14.05K
Asset deal income
----
----
----
---241.71K
---241.71K
---241.71K
---241.71K
----
----
----
Other revenue
-23.80%2.2M
8.82%2.15M
255.81%1.07M
-41.03%5.05M
-61.78%2.88M
-68.02%1.98M
33.36%300.35K
140.81%8.56M
--7.54M
218.62%6.19M
Operating profit
21.95%101.63M
27.12%67.37M
34.91%39.1M
0.27%121.97M
-10.20%83.34M
-15.51%53M
-0.15%28.98M
11.72%121.64M
92.81M
25.51%62.73M
Add:Non operating Income
856.46%63.4K
946.21%62.6K
974.10%60.8K
-99.78%8.74K
-99.83%6.63K
-99.85%5.98K
--5.66K
470.21%4.01M
--4.01M
1,350.39%4.01M
Less:Non operating expense
203.90%1.44M
70.67%434.65K
196.84%260.46K
-29.89%1.31M
-49.40%472.43K
-68.71%254.67K
-75.03%87.75K
76.96%1.87M
--933.69K
451.22%813.83K
Total profit
20.98%100.26M
27.01%67M
34.60%38.9M
-2.51%120.68M
-13.57%82.87M
-19.98%52.75M
0.79%28.9M
14.06%123.78M
95.88M
31.56%65.92M
Less:Income tax cost
21.56%13.31M
29.05%8.96M
41.34%5.51M
-1.13%16.01M
-16.47%10.95M
-23.32%6.94M
-9.28%3.9M
11.47%16.19M
--13.11M
37.99%9.05M
Net profit
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
-19.45%45.81M
2.57%25M
14.46%107.59M
82.78M
30.59%56.87M
Net profit from continuing operation
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
-19.45%45.81M
2.57%25M
14.46%107.59M
--82.78M
--56.87M
Net profit of parent company owners
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
-19.45%45.81M
2.57%25M
14.46%107.59M
--82.78M
30.59%56.87M
Earning per share
Basic earning per share
7.50%0.86
5.45%0.58
0.00%0.49
-20.38%1.68
-50.62%0.8
-50.89%0.55
2.08%0.49
14.67%2.11
--1.62
31.76%1.12
Diluted earning per share
7.50%0.86
5.45%0.58
0.00%0.49
-20.38%1.68
-50.62%0.8
-50.89%0.55
2.08%0.49
14.67%2.11
--1.62
31.76%1.12
Other composite income
Total composite income
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
-19.45%45.81M
2.57%25M
14.46%107.59M
82.78M
30.59%56.87M
Total composite income of parent company owners
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
-19.45%45.81M
2.57%25M
14.46%107.59M
--82.78M
30.59%56.87M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M-10.44%283.17M-8.50%193.37M14.87%106.95M8.69%422.78M316.17M13.27%211.34M
Operating revenue 13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M-10.44%283.17M-8.50%193.37M14.87%106.95M8.69%422.78M--316.17M13.27%211.34M
Other operating revenue -----53.80%432.99K-----28.82%1.17M-----20.47%937.11K-----25.17%1.64M------1.18M
Total operating cost 9.41%220.99M3.15%145.3M-0.08%77.41M-8.61%277.74M-10.13%201.98M-4.76%140.86M20.27%77.46M7.25%303.91M224.76M7.43%147.9M
Operating cost 10.57%187.65M5.40%124.36M4.66%70.51M-11.57%234.18M-14.85%169.7M-10.18%117.99M20.57%67.37M13.42%264.82M--199.29M15.92%131.36M
Operating tax surcharges 16.24%3.35M7.46%2.25M17.00%892.61K95.38%4.16M32.34%2.88M121.45%2.1M68.15%762.88K-31.83%2.13M--2.18M-34.12%946.82K
Operating expense 8.26%8.67M14.19%6M-10.76%1.71M4.22%10.46M4.69%8M1.61%5.26M3.04%1.92M5.22%10.04M--7.65M17.02%5.18M
Administration expense -9.05%18.2M-13.62%11.98M5.29%5.07M14.53%26.03M18.35%20.01M20.67%13.87M-2.82%4.82M-5.93%22.73M--16.91M7.14%11.49M
Financial expense -33.27%-14.69M-76.41%-10.88M-1,133.71%-5.06M-37.70%-15.94M-4.70%-11.03M10.19%-6.17M57.24%-410.42K-1,283.18%-11.58M---10.53M-1,080.33%-6.87M
-Interest expense (Financial expense) 986.72%279.12K467.99%184.52K467.99%92.26K-49.99%33.96K-50.28%25.68K-8.26%32.49K-33.95%16.24K-32.93%67.9K--51.66K-31.96%35.41K
-Interest Income (Financial expense) -32.28%-13.28M-68.25%-9.17M-213.59%-4.12M-330.91%-15.3M-348.33%-10.04M-303.92%-5.45M-126.59%-1.31M-131.28%-3.55M---2.24M-206.09%-1.35M
Research and development 43.61%17.83M48.10%11.59M42.58%4.28M19.50%18.84M33.87%12.42M34.89%7.82M35.60%3M30.65%15.77M--9.28M-17.96%5.8M
Credit Impairment Loss 50,837.53%799.76K151.35%425.21K90.25%-54.86K44.38%-427.52K99.89%-1.58K68.17%-828.11K---562.68K-764.87%-768.63K---1.46M-220.08%-2.6M
Asset Impairment Loss -21.81%-592.85K-32.50%-545.51K---306.99K-107.81%-2.44M41.90%-486.71K55.68%-411.69K----37.26%-1.17M---837.64K-20.73%-928.84K
Other net revenue 19.76%2.58M309.42%2.03M240.24%706.85K-18.50%2.26M53.63%2.15M170.32%496.32K-256.74%-504.04K-14.71%2.77M1.4M-166.10%-705.82K
Fair value change income -----------------------------200.00%-740.3K---740.3K---3.38M
Invest income --174.27K--------110.30%319.69K-------------536.86%-3.11M---3.11M-98.02%14.05K
Asset deal income ---------------241.71K---241.71K---241.71K---241.71K------------
Other revenue -23.80%2.2M8.82%2.15M255.81%1.07M-41.03%5.05M-61.78%2.88M-68.02%1.98M33.36%300.35K140.81%8.56M--7.54M218.62%6.19M
Operating profit 21.95%101.63M27.12%67.37M34.91%39.1M0.27%121.97M-10.20%83.34M-15.51%53M-0.15%28.98M11.72%121.64M92.81M25.51%62.73M
Add:Non operating Income 856.46%63.4K946.21%62.6K974.10%60.8K-99.78%8.74K-99.83%6.63K-99.85%5.98K--5.66K470.21%4.01M--4.01M1,350.39%4.01M
Less:Non operating expense 203.90%1.44M70.67%434.65K196.84%260.46K-29.89%1.31M-49.40%472.43K-68.71%254.67K-75.03%87.75K76.96%1.87M--933.69K451.22%813.83K
Total profit 20.98%100.26M27.01%67M34.60%38.9M-2.51%120.68M-13.57%82.87M-19.98%52.75M0.79%28.9M14.06%123.78M95.88M31.56%65.92M
Less:Income tax cost 21.56%13.31M29.05%8.96M41.34%5.51M-1.13%16.01M-16.47%10.95M-23.32%6.94M-9.28%3.9M11.47%16.19M--13.11M37.99%9.05M
Net profit 20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M-19.45%45.81M2.57%25M14.46%107.59M82.78M30.59%56.87M
Net profit from continuing operation 20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M-19.45%45.81M2.57%25M14.46%107.59M--82.78M--56.87M
Net profit of parent company owners 20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M-19.45%45.81M2.57%25M14.46%107.59M--82.78M30.59%56.87M
Earning per share
Basic earning per share 7.50%0.865.45%0.580.00%0.49-20.38%1.68-50.62%0.8-50.89%0.552.08%0.4914.67%2.11--1.6231.76%1.12
Diluted earning per share 7.50%0.865.45%0.580.00%0.49-20.38%1.68-50.62%0.8-50.89%0.552.08%0.4914.67%2.11--1.6231.76%1.12
Other composite income
Total composite income 20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M-19.45%45.81M2.57%25M14.46%107.59M82.78M30.59%56.87M
Total composite income of parent company owners 20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M-19.45%45.81M2.57%25M14.46%107.59M--82.78M30.59%56.87M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data